BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Lu C, Wang T, Qiao C, Lu L, Wu D, Lu M, Chen R, Fan L, Tang J. Hyperoside suppresses NLRP3 inflammasome in Parkinson's disease via Pituitary Adenylate Cyclase-Activating Polypeptide. Neurochem Int 2022;152:105254. [PMID: 34883151 DOI: 10.1016/j.neuint.2021.105254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Xia J, Wan Y, Wu JJ, Yang Y, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C. Therapeutic potential of dietary flavonoid hyperoside against non-communicable diseases: targeting underlying properties of diseases. Crit Rev Food Sci Nutr 2022;:1-31. [PMID: 36073729 DOI: 10.1080/10408398.2022.2115457] [Reference Citation Analysis]
2 Khairnar RC, Parihar N, Prabhavalkar KS, Bhatt LK. Emerging targets signaling for inflammation in Parkinson's disease drug discovery. Metab Brain Dis 2022. [PMID: 35536461 DOI: 10.1007/s11011-022-00999-2] [Reference Citation Analysis]